attachment
attachment

Answer

The correct answer is D. All of the above.
Here's why each statement is true:
A. TRUE - The DDD metric is sensitive to influences including pediatric patients and patients with renal dysfunction. DDDs are based on average adult maintenance doses, so they don't accurately reflect drug use in children (who receive weight-based dosing) or in patients with renal impairment (who receive reduced doses). This is a well-recognized limitation of the DDD metric.
B. TRUE - This is the correct technical definition of DDD. You sum the total grams of a drug used over the period of interest, then divide by the WHO-assigned DDD value (the assumed average maintenance dose per day for a drug used in its main indication in adults). The result is often expressed as DDDs per 1,000 patient-days.
C. TRUE - Days of Therapy (DOT) counts the number of calendar days a patient received at least one dose of a specific antimicrobial, regardless of the dose amount. This makes DOT less sensitive to dose adjustments and therefore more useful for pediatric populations or patients with renal dysfunction compared to DDD.
Why D is the answer: All three statements accurately describe concepts in antimicrobial stewardship metrics. The question is testing knowledge of both DDD (its calculation method and limitations) and DOT (its definition), and all three options are factually correct.
attachment
attachment

Answer

The correct answer is E. All of the above.
All four options are classic examples of electronic alerts used in antimicrobial stewardship programs (ASPs):
A. Bug-drug mismatch - An alert fires when the prescribed antibiotic does not cover the identified organism based on culture and sensitivity results (e.g., a patient is on vancomycin but the organism is gram-negative). This is one of the most high-yield stewardship interventions.
B. IV to PO conversion - An alert prompts clinicians to switch from intravenous to oral antibiotics once a patient meets criteria (tolerating PO, improving clinically, adequate oral bioavailability of the drug). This reduces line complications, costs, and length of stay.
C. Duplicate therapy - An alert flags when two agents from the same class or with overlapping spectra are prescribed simultaneously (e.g., two anaerobic agents, or two drugs with redundant gram-positive coverage).
D. Duration of therapy / antibiotic timeout - An alert triggers at a set time point (commonly 48-72 hours) prompting reassessment of whether the antibiotic is still indicated, whether the indication, dose, and duration remain appropriate. This is a core stewardship strategy to prevent unnecessarily prolonged courses.
All of these are well-established electronic alert types built into clinical decision support systems as part of antimicrobial stewardship, making E the correct answer.
attachment
attachment

Answer

The correct answer is D. Identifying definitive interventions that allow providers to bypass decision making.
Here's the reasoning:
A. Intervention tracking - IS a function of CDSS Clinical decision support systems track stewardship interventions (e.g., pharmacist recommendations, alert responses) to measure program performance and document outcomes.
B. Cost savings quantification - IS a function of CDSS CDSS platforms can calculate and report cost savings associated with stewardship interventions, such as IV-to-PO switches, de-escalation, or avoided unnecessary therapy.
C. Antibiotic utilization tracking - IS a function of CDSS Tracking antibiotic use (DDDs, DOTs, expenditure) over time is a core CDSS capability, essential for benchmarking and identifying areas for improvement.
D. NOT a function of CDSS - this is the correct "except" answer The purpose of a clinical decision support system is to support and guide clinical decision making, not to bypass it. CDSS presents relevant information, alerts, and recommendations to clinicians, who then make the final decision. Allowing providers to bypass decision making entirely would defeat the purpose of the system and is contrary to the principles of good stewardship and patient safety. The goal is informed decision-making, not circumventing it.
This is a shared conversation. Sign in to Orris to start your own chat.